Brief: Market Capital Recommends Aurinia Shareholders Withhold Support For Chairman George Milne At Annual Meeting
05/05/2023 16:06
May 5 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O :
* MARKET CAPITAL: RECOMMENDS AURINIA SHAREHOLDERS WITHHOLD SUPPORT FOR
CHAIRMAN
GEORGE MILNE, CEO PETER GREENLEAF AND COMPENSATION COMMITTEE CHAIR AT ANNUAL
MEETING
Further company coverage: AUPH.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death